ETPharma.com brings latest weight loss drug news, views and updates from all top sources for the Indian Pharma industry.

ETPharma.com brings latest clinical trial results news, views and updates from all top sources for the Indian Pharma industry.

British drugmaker GSK markets Shingrix, a vaccine for shingles, a painful viral infection that causes blisters and rashes, while Pfizer and Moderna are the leading makers of COVID-19 vaccines.

Novo Nordisk, the maker of Ozempic, aims to enter the hair-loss market as part of its strategy to diversify and leverage its ...

Amgen's late-stage trial results for dazodalibep, an experimental drug for Sjogren's disease, indicate significant reduction in disease activity, leading to a 4% surge in shares. Discover the ...

European pharmaceutical companies urge governments to enhance spending and streamline drug trials to compete with the US and ...

Cohance Lifesciences' API manufacturing site in Andhra Pradesh has received a Form 483 with five observations from the FDA, ...

New York: A federal appeals court on Monday revived more than 500 private lawsuits against Tylenol maker Kenvue over the painkiller's alleged link to autism. The 2nd U.S. Circuit Court of Appeals in ...

The sale comes amid rising competition from brands such as Ayvakit, marketed by French major Sanofi. However, direct generic competition is expected to arrive only after 2029 in Europe and 2030 in the ...

Approximately 96% completion, every certificate accounted for, with nothing overdue – this is what a quality head at an Indian formulation plant can pull up from her training dashboard in less than a ...

India's DCGI warns against the indiscriminate use of painkillers and antibiotics due to risks of chronic kidney disease, urging healthcare professionals to adhere to strict guidelines for medication.

Of the total 220 NSQ samples identified in August, includes several common medicines such as paracetamol, metformin combos (for diabetes), amoxicillin formulations (antibiotics), vitamin supplements ...